217 related articles for article (PubMed ID: 3032782)
1. C1 activation and dissociation in disease.
Laurell AB; Mårtensson U; Sjöholm AG
Immunol Lett; 1987 Feb; 14(3):249-53. PubMed ID: 3032782
[TBL] [Abstract][Full Text] [Related]
2. C1 dissociation. Spontaneous generation in human serum of a trimer complex containing C1 inactivator, activated C1r, and zymogen C1s.
Laurell AB; Mårtensson U; Sjöholm AG
J Immunol; 1987 Dec; 139(12):4145-51. PubMed ID: 2826582
[TBL] [Abstract][Full Text] [Related]
3. Trimer and tetramer complexes containing C1 esterase inhibitor, C1r and C1s, in serum and synovial fluid of patients with rheumatic disease.
Laurell AB; Mårtensson U; Sjöholm AG
J Immunol Methods; 1990 May; 129(1):55-61. PubMed ID: 2338498
[TBL] [Abstract][Full Text] [Related]
4. C1 subcomponent complexes: basic and clinical aspects.
Laurell AB; Sjöholm AG
Behring Inst Mitt; 1993 Dec; (93):292-8. PubMed ID: 8172579
[TBL] [Abstract][Full Text] [Related]
5. C1 activation, with C1q in excess of functional C1 in synovial fluid from patients with rheumatoid arthritis.
Sjöholm AG; Berglund K; Johnson U; Laurell AB; Sturfelt G
Int Arch Allergy Appl Immunol; 1986; 79(2):113-9. PubMed ID: 3484727
[TBL] [Abstract][Full Text] [Related]
6. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.
Peitsch MC; Kovacsovics TJ; Tschopp J; Isliker H
J Immunol; 1987 Mar; 138(6):1871-6. PubMed ID: 3029223
[TBL] [Abstract][Full Text] [Related]
7. Binding of purified C1 subcomponents, C1 inactivator and their complexes to immobilized heparin.
McKay EJ; Johnson U; Laurell AB; Mårtensson U; Sjöholm AG
Acta Pathol Microbiol Scand C; 1981 Oct; 89(5):339-44. PubMed ID: 6274149
[TBL] [Abstract][Full Text] [Related]
8. Complement activation, circulating C1q binding substances and inflammatory activity in rheumatoid arthritis: relations and changes on suppression of inflammation.
Berglund K; Laurell AB; Nived O; Sjoholm AG; Sturfelt G
J Clin Lab Immunol; 1980 Jul; 4(1):7-14. PubMed ID: 7463476
[TBL] [Abstract][Full Text] [Related]
9. Fluid-phase interaction of C1 inhibitor (C1 Inh) and the subcomponents C1r and C1s of the first component of complement, C1.
Chesne S; Villiers CL; Arlaud GJ; Lacroix MB; Colomb MG
Biochem J; 1982 Jan; 201(1):61-70. PubMed ID: 6282262
[TBL] [Abstract][Full Text] [Related]
10. Antibody-independent activation of C1. I. Differences in the mechanism of C1 activation by nonimmune activators and by immune complexes: C1r-independent activation of C1s by cardiolipin vesicles.
Kovacsovics TJ; Peitsch MC; Kress A; Isliker H
J Immunol; 1987 Mar; 138(6):1864-70. PubMed ID: 3029222
[TBL] [Abstract][Full Text] [Related]
11. Activation of the first component of human complement (C1) by antibody-antigen aggregates.
Dodds AW; Sim RB; Porter RR; Kerr MA
Biochem J; 1978 Nov; 175(2):383-90. PubMed ID: 743203
[TBL] [Abstract][Full Text] [Related]
12. Quantitation of (C1INH)2 C1r-C1s complexes in glomerulonephritis as an indicator of C1 activation.
Waldo FB; West CD
Clin Immunol Immunopathol; 1987 Feb; 42(2):239-49. PubMed ID: 3026704
[TBL] [Abstract][Full Text] [Related]
13. C1 subcomponent complexes and C2 cleavage in active systemic lupus erythematosus.
Jonsson H; Sjöholm AG; Mårtensson U; Laurell AB; Sturfelt G
Complement Inflamm; 1991; 8(1):1-12. PubMed ID: 2049932
[TBL] [Abstract][Full Text] [Related]
14. C1 inactivator-C1s complexes in inflammatory joint disease.
Inman RD; Harpel PC
Clin Exp Immunol; 1983 Sep; 53(3):521-8. PubMed ID: 6604603
[TBL] [Abstract][Full Text] [Related]
15. Lack of activation of C1, despite circulating immune complexes detected by two C1q methods, in patients with rheumatoid arthritis.
Hack CE; Eerenberg-Belmer AJ; Lim UG; Haverman J; Aalberse RC
Arthritis Rheum; 1984 Jan; 27(1):40-8. PubMed ID: 6318777
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and regulation of C1 inhibitor in human skin fibroblasts.
Katz Y; Strunk RC
J Immunol; 1989 Mar; 142(6):2041-5. PubMed ID: 2537870
[TBL] [Abstract][Full Text] [Related]
17. Complement components, C1 activation and disease activity in SLE.
Sturfelt G; Sjöholm AG; Svensson B
Int Arch Allergy Appl Immunol; 1983; 70(1):12-8. PubMed ID: 6293980
[TBL] [Abstract][Full Text] [Related]
18. C1 subcomponent conplexes in normal and pathological sera studied by crossed immunoelectrophoresis.
Laurell AB; Mårtensson U; Sjöholm AG
Acta Pathol Microbiol Scand C; 1976 Dec; 84C(6):455-64. PubMed ID: 998270
[TBL] [Abstract][Full Text] [Related]
19. Physicochemical and functional characterization of the C1r subunit of the first complement component.
Ziccardi RJ; Cooper NR
J Immunol; 1976 Feb; 116(2):496-503. PubMed ID: 814163
[TBL] [Abstract][Full Text] [Related]
20. Terminal complement complexes and C1/C1 inhibitor complexes in rheumatoid arthritis and other arthritic conditions.
Oleesky DA; Daniels RH; Williams BD; Amos N; Morgan BP
Clin Exp Immunol; 1991 May; 84(2):250-5. PubMed ID: 2025952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]